Effective Alloreactive NK Cell Therapy for Breast Cancer In Mice Requires Conditioning with Cyclophosphamide and Total Body Irradiation but Not Bone Marrow Engraftment
Michel Van Gelder , Peter Frings , Catarina Matos , Harry C. Schouten
Blood 116 ( 21) 2085 -2085
2010
Role of Human NK Cells in Dentric-Cell Based Vaccine.
Gerard M.J. Bos , Janine CHMJ Van Elssen , Joris Vanderlocht , Brigitte LMG Senden-Gijsbers
Blood 112 ( 11) 1550 -1550
2008
Final Analysis of HOVON-50 Randomized Phase III Study on the Effect of Thalidomide Combined with Adriamycine, Dexamethasone (AD) and High Dose Melphalan (HDM) in Patients with Multiple Myeloma (MM)
Henk Lokhorst , Bronno van der Holt , Sonja Zweegman , Peter A. Von Dem Borne
Blood 112 ( 11) 64 -65
15
2008
Bortezomib Induction and Maintenance in Patients with Newly Diagnosed Multiple Myeloma: Long-Term Follow-up of the HOVON-65/GMMG-HD4 Trial
Pieter Sonneveld , Hans-Juergen Salwender , Bronno Van Der Holt , Laila el Jarari
Blood 126 ( 23) 27 -27
27
2015
Rosuvastatin Enhances VSV-G Lentiviral Transduction of NK Cells via Upregulation of the Low-Density Lipoprotein Receptor.
Ying Gong , Roel G.J. Klein Wolterink , Ian Janssen , Arjan J. Groot
Molecular therapy. Methods & clinical development 17 634 -646
3
2020
53-OR: HLA class I and HLA-E influence susceptibility of multiple myeloma cells to elimination by NK cells
Subhashis Sarkar , Richard W. Groen , Anton C.M. Martens , Gerard M.J. Bos
Human Immunology 72
2011
OR35: THE DYNAMICS OF SERUM FREE LIGHT CHAIN IMMUNOGLOBULINS AFTER KIDNEY TRANSPLANTATION
Thomas H.P.M. Habets , Stefan J.J. Molenbroeck , Jacqueline J.Y. Frijns , Els Bielen
Human Immunology 75 31
1
2014
A Phase I Study of Allogeneic Natural Killer Cell Therapy Generated from Cord Blood Hematopoietic Stem and Progenitor Cells in Elderly Acute Myeloid Leukemia Patients
Harry Dolstra , Mieke W.H. Roeven , Jan Spanholtz , Basav Hangalapura
Blood 126 ( 23) 1357 -1357
6
2015
Phase I/II trial of weekly bortezomib with lenalidomide and dexamethasone in first relapse or primary refractory myeloma
Annemiek Broijl , Marie-José Kersten , Wendimagegn Ghidey Alemayehu , Mark-David Levin
Haematologica 101 ( 4) 149 -152
7
2016
Cereblon loss and up-regulation of c-Myc are associated with lenalidomide resistance in multiple myeloma patients
Laurens E. Franssen , Inger S. Nijhof , Suzana Couto , Mark-David Levin
Haematologica 103 ( 8)
17
2018
No Improvement Of Overall Survival After Extended Follow-Up Of Donor Versus No Donor Analysis Of Newly Diagnosed Myeloma Patients Included In The HOVON 50/54 Study
Henk Lokhorst , Bronno van der Holt , Jan Cornelissen , Marie José Kersten
Blood 122 ( 21) 2132 -2132
1
2013
The development of D antibodies after D-mismatched kidney transplantation in a setting of reduced immunosuppression
Thomas H.P.M. Habets , Joris Vanderlocht , Ron J.M.H.E. Straat , Tim C. van Smaalen
Transfusion 58 ( 1) 100 -104
1
2018
The Impact of Allogeneic Stem Cell Transplantation As Part of First Line Treatment on Outcome of Patients with Multiple Myeloma Depends on the Method of Analysis
Raynier Devillier , Jurjen Versluis , Bronno Van der Holt , Marie Jose Kersten
Blood 124 ( 21) 1209 -1209
1
2014
Randomized Phase III Trial in Non-Transplant Eligible Patients with Newly Diagnosed Symptomatic Multiple Myeloma Comparing Melphalan-Prednisone-Thalidomide Followed By Thalidomide Maintenance (MPT-T) Versus Melphalan-Prednisone-Lenalidomide Followed By Maintenance with Lenalidomide (MPR-R); A Joint Study of the Dutch-Belgian Cooperative Trial Group for Hematology Oncology (HOVON) and the Nordic Myeloma Study Group (NMSG)
Sonja Zweegman , Bronno van der Holt , Ulf-Henrik Mellqvist , Morten Salomo
Blood 124 ( 21) 179 -179
8
2014
The Perception of Shared Decision-Making in Hematology by Patients and Physicians Seems Satisfactory, but Important Steps are Still Ahead of Us.
Gerard M.J. Bos , Paulus A.F. Geerts , Trudy van der Weijden , Albine Moser
HemaSphere 4 ( 4)
2020
Murine dendritic cells that are resistant to maturation are unable to induce tolerance to allogeneic stem cells
Ariane Vanclée , Harry C. Schouten , Gerard M.J. Bos
Transplant Immunology 16 ( 1) 8 -13
4
2006
Chronic cyclosporine-induced autoimmune disease in the rat: a new experimental model for scleroderma.
Gerard M.J. Bos , Gerard D. Majoor , Roelof G.J. Willighagen , Peter J.C. van Breda Vriesman
Journal of Investigative Dermatology 93 ( 5) 610 -615
13
1989
Describing patients’ needs in the context of research priorities in patients with multiple myeloma or Waldenstrom's disease: A truly patient-driven study
Tiny van Merode , Silvia Bours , Ben van Steenkiste , Theo Sijbers
Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen 112 11 -18
9
2016
Phase I/II Trial of Weekly Escalated Dose Bortezomib Combined with Lenalidomide and Dexamethasone in Patients in First Relapse or Primary Refractory Disease after First Line Therapy for Multiple Myeloma
Annemiek Broijl , Marie José Kersten , Wendim Ghidey Alemayehu , Mark-David Levin
Blood 124 ( 21) 4735 -4735
2
2014
Flow cytometry-based assay to evaluate human serum MUC1-Tn antibodies
Catharina H.M.J. Van Elssen , Henrik Clausen , Wilfred T.V. Germeraad , Eric P. Bennet
Journal of Immunological Methods 365 ( 1-2) 87 -94
11
2011